With TARIS’ approach, patients can spend their time enjoying life, not managing disease.
We achieve unprecedented clinical outcomes by integrating our deep understanding of bladder biology with unique access to disease targets and optimized drug molecule selection.
We’re revolutionizing the treatment of bladder cancer, overactive bladder and other high-need urologic conditions.
“ The bladder is an intelligent organ with a surprisingly rich immune environment. TARIS is translating this knowledge into a new generation of urologic medicines. ”
Christopher J. Cutie, M.D.,
Chief Medical Officer